-
1
-
-
0029758487
-
Molecular control of vertebrate iron metabolism: MRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
-
DOI 10.1073/pnas.93.16.8175
-
Hentze, M. W. and Kuhn, L. C. (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc. Natl. Acad. Sci. U.S.A. 93, 8175-8182 (Pubitemid 26269529)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.16
, pp. 8175-8182
-
-
Hentze, M.W.1
Kuhn, L.C.2
-
2
-
-
0031567095
-
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
-
DOI 10.1016/S0304-4157(96)00014-7, PII S0304415796000147
-
Richardson, D. R. and Ponka, P. (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells Biochim. Biophys. Acta 1331, 1-40 (Pubitemid 27168147)
-
(1997)
Biochimica et Biophysica Acta - Reviews on Biomembranes
, vol.1331
, Issue.1
, pp. 1-40
-
-
Richardson, D.R.1
Ponka, P.2
-
3
-
-
31344478802
-
The redox couple of the cytochrome c cyanide complex: The contribution of heme iron ligation to the structural stability, chemical reactivity, and physiological behavior of horse cytochrome c
-
DOI 10.1110/ps.051825906
-
Schejter, A., Ryan, M. D., Blizzard, E. R., Zhang, C., Margoliash, E., and Feinberg, B. A. (2006) The redox couple of the cytochrome c cyanide complex: The contribution of heme iron ligation to the structural stability, chemical reactivity, and physiological behavior of horse cytochrome c Protein Sci. 15, 234-241 (Pubitemid 43144995)
-
(2006)
Protein Science
, vol.15
, Issue.2
, pp. 234-241
-
-
Schejter, A.1
Ryan, M.D.2
Blizzard, E.R.3
Zhang, C.4
Margoliash, E.5
Feinberg, B.A.6
-
4
-
-
0015890741
-
Iron and free radical in ribonucleotide reductase. Exchange of iron and Mossbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme
-
Atkin, C. L., Thelander, L., Reichard, P., and Lang, G. (1973) Iron and free radical in ribonucleotide reductase. Exchange of iron and Mossbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme J. Biol. Chem. 248, 7464-7472
-
(1973)
J. Biol. Chem.
, vol.248
, pp. 7464-7472
-
-
Atkin, C.L.1
Thelander, L.2
Reichard, P.3
Lang, G.4
-
5
-
-
1642308134
-
Neurodegenerative diseases and oxidative stress
-
Barnham, K. J., Masters, C. L., and Bush, A. I. (2004) Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discovery 3, 205-214
-
(2004)
Nat. Rev. Drug Discovery
, vol.3
, pp. 205-214
-
-
Barnham, K.J.1
Masters, C.L.2
Bush, A.I.3
-
6
-
-
78149246362
-
The hazards of iron loading
-
Weinberg, E. D. (2010) The hazards of iron loading Metallomics 2, 732-740
-
(2010)
Metallomics
, vol.2
, pp. 732-740
-
-
Weinberg, E.D.1
-
7
-
-
0037411115
-
β-Thalassaemia: Emergence of new and improved iron chelators for treatment
-
DOI 10.1016/S1357-2725(03)00046-3
-
Wong, C. and Richardson, D. R. (2003) Beta-thalassaemia: emergence of new and improved iron chelators for treatment Int. J. Biochem. Cell Biol. 35, 1144-1149 (Pubitemid 36369501)
-
(2003)
International Journal of Biochemistry and Cell Biology
, vol.35
, Issue.7
, pp. 1144-1149
-
-
Wong, C.1
Richardson, D.R.2
-
8
-
-
0031001278
-
Iron-chelating therapy and the treatment of thalassemia
-
Olivieri, N. F. and Brittenham, G. M. (1997) Iron-chelating therapy and the treatment of thalassemia Blood 89, 739-761 (Pubitemid 27121266)
-
(1997)
Blood
, vol.89
, Issue.3
, pp. 739-761
-
-
Olivieri, N.F.1
Brittenham, G.M.2
-
9
-
-
14944387002
-
Iron trafficking in the mitochondrion: Novel pathways revealed by disease
-
DOI 10.1182/blood-2004-10-3856
-
Napier, I., Ponka, P., and Richardson, D. R. (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease Blood 105, 1867-1874 (Pubitemid 40731766)
-
(2005)
Blood
, vol.105
, Issue.5
, pp. 1867-1874
-
-
Napier, I.1
Ponka, P.2
Richardson, D.R.3
-
10
-
-
0030763856
-
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
-
Fleming, M. D., Trenor, C. C., 3rd, Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., and Andrews, N. C. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene Nat. Genet. 16, 383-386 (Pubitemid 27323306)
-
(1997)
Nature Genetics
, vol.16
, Issue.4
, pp. 383-386
-
-
Fleming, M.D.1
Trenor III, C.C.2
Su, M.A.3
Foernzler, D.4
Beier, D.R.5
Dietrich, W.E.6
Andrews, N.C.7
-
11
-
-
29844457587
-
The evolution of iron chelators for the treatment of iron overload disease and cancer
-
DOI 10.1124/pr.57.4.2
-
Kalinowski, D. S. and Richardson, D. R. (2005) The evolution of iron chelators for the treatment of iron overload disease and cancer Pharmacol. Rev. 57, 547-583 (Pubitemid 43036441)
-
(2005)
Pharmacological Reviews
, vol.57
, Issue.4
, pp. 547-583
-
-
Kalinowski, D.S.1
Richardson, D.R.2
-
12
-
-
0037631496
-
Iron chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity
-
DOI 10.1002/ajh.10348
-
Chaston, T. B. and Richardson, D. R. (2003) Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity Am. J. Hematol. 73, 200-210 (Pubitemid 36753964)
-
(2003)
American Journal of Hematology
, vol.73
, Issue.3
, pp. 200-210
-
-
Chaston, T.B.1
Richardson, D.R.2
-
13
-
-
33750716051
-
Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases
-
DOI 10.1016/j.spen.2006.08.008, PII S1071909106001070
-
Whitnall, M. and Richardson, D. R. (2006) Iron: a new target for pharmacological intervention in neurodegenerative diseases Semin. Pediatr. Neurol. 13, 186-197 (Pubitemid 44709656)
-
(2006)
Seminars in Pediatric Neurology
, vol.13
, Issue.3
, pp. 186-197
-
-
Whitnall, M.1
Richardson, D.R.2
-
14
-
-
47749130452
-
The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation
-
DOI 10.1073/pnas.0804261105
-
Whitnall, M., Rahmanto, Y. S., Sutak, R., Xu, X., Becker, E. M., Mikhael, M. R., Ponka, P., and Richardson, D. R. (2008) The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation Proc. Natl. Acad. Sci. U.S.A. 105, 9757-9762 (Pubitemid 352031373)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.28
, pp. 9757-9762
-
-
Whitnall, M.1
Rahmanto, Y.S.2
Sutak, R.3
Xu, X.4
Becker, E.M.5
Mikhael, M.R.6
Ponka, P.7
Richardson, D.R.8
-
15
-
-
10644257442
-
Iron chelators in cancer chemotherapy
-
DOI 10.2174/1568026043387269
-
Buss, J. L., Greene, B. T., Turner, J., Torti, F. M., and Torti, S. V. (2004) Iron chelators in cancer chemotherapy Curr. Top. Med. Chem. 4, 1623-1635 (Pubitemid 39654453)
-
(2004)
Current Topics in Medicinal Chemistry
, vol.4
, Issue.15
, pp. 1623-1635
-
-
Buss, J.L.1
Greene, B.T.2
Turner, J.3
Torti, F.M.4
Torti, S.V.5
-
16
-
-
2442698003
-
Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion
-
DOI 10.1200/JCO.2004.07.158
-
Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., and Sznol, M. (2004) Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-h intravenous continuous infusion J. Clin. Oncol. 22, 1553-1563 (Pubitemid 41079792)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.9
, pp. 1553-1563
-
-
Wadler, S.1
Makower, D.2
Clainmont, C.3
Lambert, P.4
Fehn, K.5
Sznol, M.6
-
17
-
-
33749515083
-
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
-
DOI 10.1073/pnas.0604979103
-
Whitnall, M., Howard, J., Ponka, P., and Richardson, D. R. (2006) A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics Proc. Natl. Acad. Sci. U.S.A. 103, 14901-14906 (Pubitemid 44527826)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.40
, pp. 14901-14906
-
-
Whitnall, M.1
Howard, J.2
Ponka, P.3
Richardson, D.R.4
-
18
-
-
8444235919
-
Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation
-
DOI 10.1158/1078-0432.CCR-04-0865
-
Chaston, T. B., Watts, R. N., Yuan, J., and Richardson, D. R. (2004) Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation Clin. Cancer Res. 10, 7365-7374 (Pubitemid 39487726)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.21
, pp. 7365-7374
-
-
Chaston, T.B.1
Watts, R.N.2
Yuan, J.3
Richardson, D.R.4
-
19
-
-
76749092292
-
Phase i trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer
-
Kunos, C. A., Waggoner, S., von Gruenigen, V., Eldermire, E., Pink, J., Dowlati, A., and Kinsella, T. J. (2010) Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer Clin. Cancer Res. 16, 1298-1306
-
(2010)
Clin. Cancer Res.
, vol.16
, pp. 1298-1306
-
-
Kunos, C.A.1
Waggoner, S.2
Von Gruenigen, V.3
Eldermire, E.4
Pink, J.5
Dowlati, A.6
Kinsella, T.J.7
-
20
-
-
66949171305
-
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
-
Simunek, T., Sterba, M., Popelova, O., Adamcova, M., Hrdina, R., and Gersl, V. (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron Pharmacol. Rep. 61, 154-171
-
(2009)
Pharmacol. Rep.
, vol.61
, pp. 154-171
-
-
Simunek, T.1
Sterba, M.2
Popelova, O.3
Adamcova, M.4
Hrdina, R.5
Gersl, V.6
-
21
-
-
29744461403
-
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
-
DOI 10.1196/annals.1345.014
-
Rachmilewitz, E. A., Weizer-Stern, O., Adamsky, K., Amariglio, N., Rechavi, G., Breda, L., Rivella, S., and Cabantchik, Z. I. (2005) Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants? Ann. N.Y. Acad. Sci. 1054, 118-123 (Pubitemid 43031016)
-
(2005)
Annals of the New York Academy of Sciences
, vol.1054
, pp. 118-123
-
-
Rachmilewitz, E.A.1
Weizer-Stern, O.2
Adamsky, K.3
Amariglio, N.4
Rechavi, G.5
Breda, L.6
Rivella, S.7
Cabantchik, Z.I.8
-
22
-
-
79952917106
-
Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis
-
10.1021/tx100359t
-
Hruskova, K., Kovarikova, P., Bendova, P., Haskova, P., Mackova, E., Stariat, J., Vavrova, A., Vavrova, K., and Simunek, T. (2011) Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis Chem. Res. Toxicol. 10.1021/tx100359t
-
(2011)
Chem. Res. Toxicol.
-
-
Hruskova, K.1
Kovarikova, P.2
Bendova, P.3
Haskova, P.4
MacKova, E.5
Stariat, J.6
Vavrova, A.7
Vavrova, K.8
Simunek, T.9
-
23
-
-
77955444881
-
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy
-
Turer, A. T. and Hill, J. A. (2010) Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy Am. J. Cardiol. 106, 1521-1522
-
(2010)
Am. J. Cardiol.
, vol.106
, pp. 1521-1522
-
-
Turer, A.T.1
Hill, J.A.2
-
24
-
-
0026538966
-
Iron chelation in myocardial preservation after ischemia-reperfusion injury: The importance of pretreatment and toxicity
-
DeBoer, D. A. and Clark, R. E. (1992) Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity Ann. Thorac. Surg. 53, 412-418
-
(1992)
Ann. Thorac. Surg.
, vol.53
, pp. 412-418
-
-
Deboer, D.A.1
Clark, R.E.2
-
25
-
-
0033067885
-
Iron-mediated cardiovascular injury
-
Horwitz, L. D. and Rosenthal, E. A. (1999) Iron-mediated cardiovascular injury Vasc. Med. 4, 93-99 (Pubitemid 29290825)
-
(1999)
Vascular Medicine
, vol.4
, Issue.2
, pp. 93-99
-
-
Horwitz, L.D.1
Rosenthal, E.A.2
-
26
-
-
0032994468
-
Effect of deferoxamine on post-hypoxic-ischemic reperfusion injury of the newborn lamb heart
-
Shadid, M., Van Bel, F., Steendijk, P., Dorrepaal, C. A., Moison, R., Van Der Velde, E. T., and Baan, J. (1999) Effect of deferoxamine on post-hypoxic-ischemic reperfusion injury of the newborn lamb heart Biol. Neonate 75, 239-249 (Pubitemid 29112511)
-
(1999)
Biology of the Neonate
, vol.75
, Issue.4
, pp. 239-249
-
-
Shadid, M.1
Van Bel, F.2
Steendijk, P.3
Dorrepaal, C.A.4
Moison, R.5
Van Der Velde, E.T.6
Baan, J.7
-
27
-
-
0026007641
-
Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs
-
Maruyama, M., Pieper, G. M., Kalyanaraman, B., Hallaway, P. E., Hedlund, B. E., and Gross, G. J. (1991) Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs J. Cardiovasc. Pharmacol. 17, 166-175
-
(1991)
J. Cardiovasc. Pharmacol.
, vol.17
, pp. 166-175
-
-
Maruyama, M.1
Pieper, G.M.2
Kalyanaraman, B.3
Hallaway, P.E.4
Hedlund, B.E.5
Gross, G.J.6
-
28
-
-
0033989136
-
First human studies with a high-molecular-weight iron chelator
-
Dragsten, P. R., Hallaway, P. E., Hanson, G. J., Berger, A. E., Bernard, B., and Hedlund, B. E. (2000) First human studies with a high-molecular-weight iron chelator J. Lab. Clin. Med. 135, 57-65 (Pubitemid 30042154)
-
(2000)
Journal of Laboratory and Clinical Medicine
, vol.135
, Issue.1
, pp. 57-65
-
-
Dragsten, P.R.1
Hallaway, P.E.2
Hanson, G.J.3
Berger, A.E.4
Bernard, B.5
Hedlund, B.E.6
-
29
-
-
0018394556
-
Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent
-
DOI 10.1016/0014-5793(79)80111-8
-
Ponka, P., Borova, J., Neuwirt, J., and Fuchs, O. (1979) Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent FEBS Lett. 97, 317-321 (Pubitemid 9112866)
-
(1979)
FEBS Letters
, vol.97
, Issue.2
, pp. 317-321
-
-
Ponka, P.1
Borova, J.2
Neuwirt, J.3
Fuchs, O.4
-
30
-
-
0023780401
-
Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes
-
Ponka, P., Richardson, D., Baker, E., Schulman, H. M., and Edward, J. T. (1988) Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes Biochim. Biophys. Acta 967, 122-129
-
(1988)
Biochim. Biophys. Acta
, vol.967
, pp. 122-129
-
-
Ponka, P.1
Richardson, D.2
Baker, E.3
Schulman, H.M.4
Edward, J.T.5
-
31
-
-
77953792874
-
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury
-
Bendova, P., Mackova, E., Haskova, P., Vavrova, A., Jirkovsky, E., Sterba, M., Popelova, O., Kalinowski, D. S., Kovarikova, P., Vavrova, K., Richardson, D. R., and Simunek, T. (2010) Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury Chem. Res. Toxicol. 23, 1105-1114
-
(2010)
Chem. Res. Toxicol.
, vol.23
, pp. 1105-1114
-
-
Bendova, P.1
MacKova, E.2
Haskova, P.3
Vavrova, A.4
Jirkovsky, E.5
Sterba, M.6
Popelova, O.7
Kalinowski, D.S.8
Kovarikova, P.9
Vavrova, K.10
Richardson, D.R.11
Simunek, T.12
-
32
-
-
50249149460
-
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
-
Simunek, T., Sterba, M., Popelova, O., Kaiserova, H., Adamcova, M., Hroch, M., Haskova, P., Ponka, P., and Gersl, V. (2008) Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone Br. J. Pharmacol. 155, 138-148
-
(2008)
Br. J. Pharmacol.
, vol.155
, pp. 138-148
-
-
Simunek, T.1
Sterba, M.2
Popelova, O.3
Kaiserova, H.4
Adamcova, M.5
Hroch, M.6
Haskova, P.7
Ponka, P.8
Gersl, V.9
-
33
-
-
34248384887
-
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
-
DOI 10.1016/j.tox.2007.03.020, PII S0300483X07001813
-
Sterba, M., Popelova, O., Simunek, T., Mazurova, Y., Potacova, A., Adamcova, M., Guncova, I., Kaiserova, H., Palicka, V., Ponka, P., and Gersl, V. (2007) Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) Toxicology 235, 150-166 (Pubitemid 46734545)
-
(2007)
Toxicology
, vol.235
, Issue.3
, pp. 150-166
-
-
Sterba, M.1
Popelova, O.2
Simunek, T.3
Mazurova, Y.4
Potacova, A.5
Adamcova, M.6
Guncova, I.7
Kaiserova, H.8
Palicka, V.9
Ponka, P.10
Gersl, V.11
-
34
-
-
33745205646
-
Intralysosomal iron chelation protects against oxidative stress-induced cellular damage
-
Kurz, T., Gustafsson, B., and Brunk, U. T. (2006) Intralysosomal iron chelation protects against oxidative stress-induced cellular damage FEBS J. 273, 3106-3117
-
(2006)
FEBS J.
, vol.273
, pp. 3106-3117
-
-
Kurz, T.1
Gustafsson, B.2
Brunk, U.T.3
-
35
-
-
22244446427
-
SIH - A novel lipophilic iron chelator - Protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death
-
DOI 10.1016/j.yjmcc.2005.05.008, PII S002228280500163X
-
Simunek, T., Boer, C., Bouwman, R. A., Vlasblom, R., Versteilen, A. M., Sterba, M., Gersl, V., Hrdina, R., Ponka, P., de Lange, J. J., Paulus, W. J., and Musters, R. J. (2005) SIH, a novel lipophilic iron chelator, protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death J. Mol. Cell Cardiol. 39, 345-354 (Pubitemid 40995024)
-
(2005)
Journal of Molecular and Cellular Cardiology
, vol.39
, Issue.2
, pp. 345-354
-
-
Simunek, T.1
Boer, C.2
Bouwman, R.A.3
Vlasblom, R.4
Versteilen, A.M.G.5
Sterba, M.6
Gersl, V.7
Hrdina, R.8
Ponka, P.9
De Lange, J.J.10
Paulus, W.J.11
Musters, R.J.P.12
-
36
-
-
23944448097
-
Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study
-
DOI 10.1002/jssc.200500077
-
Kovarikova, P., Klimes, J., Sterba, M., Popelova, O., Mokry, M., Gersl, V., and Ponka, P. (2005) Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study J. Sep. Sci. 28, 1300-1306 (Pubitemid 41195339)
-
(2005)
Journal of Separation Science
, vol.28
, Issue.12
, pp. 1300-1306
-
-
Kovarikova, P.1
Klimes, J.2
Sterba, M.3
Popelova, O.4
Mokry, M.5
Gersl, V.6
Ponka, P.7
-
37
-
-
78249275855
-
BAY 11-7082, a nuclear factor-kappaB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model
-
Kim, Y. S., Kim, J. S., Kwon, J. S., Jeong, M. H., Cho, J. G., Park, J. C., Kang, J. C., and Ahn, Y. (2010) BAY 11-7082, a nuclear factor-kappaB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model Int. Heart J. 51, 348-353
-
(2010)
Int. Heart J.
, vol.51
, pp. 348-353
-
-
Kim, Y.S.1
Kim, J.S.2
Kwon, J.S.3
Jeong, M.H.4
Cho, J.G.5
Park, J.C.6
Kang, J.C.7
Ahn, Y.8
-
38
-
-
0034524377
-
In vivo models of myocardial ischemia and reperfusion injury: Application to drug discovery and evaluation
-
DOI 10.1016/S1056-8719(00)00102-7, PII S1056871900001027
-
Black, S. C. (2000) In vivo models of myocardial ischemia and reperfusion injury: application to drug discovery and evaluation J. Pharmacol. Toxicol. Methods 43, 153-167 (Pubitemid 32057037)
-
(2000)
Journal of Pharmacological and Toxicological Methods
, vol.43
, Issue.2
, pp. 153-167
-
-
Black, S.C.1
|